1.Clinical manifestations and diagnosis of systemic lupus erythematosus.
Korean Journal of Medicine 2010;78(4):409-415
Systemic lupus erythematosus (SLE) is a multi-system, autoimmune disorder of unknown cause, characterized by the production of autoantibodies and wide ranging spectrum of clinical manifestations. SLE can involve any organ system of the body with constitutional symptoms, including musculoskeletal, skin, renal, neuropsychiatric, cardiovascular, respiratory and gastrointestinal system. American College of Rheumatology classifications criteria for SLE can be helpful when establishing the diagnosis of SLE. However, these criteria would not do for physicians to give a diagnosis of SLE because these were designed for classification for research purpose and not for diagnosis. The diagnosis of SLE remains largely clinical. Thus, increasing awareness of the clinical manifestations could lead to earlier diagnosis. The clinical manifestations and diagnosis of SLE are covered in this review.
Autoantibodies
;
Lupus Erythematosus, Systemic
;
Rheumatology
;
Skin
2.Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean
Journal of Rheumatic Diseases 2023;30(2):88-98
Gout is the most common form of inflammatory arthritis that affects mainly middle-aged men, and there is clear evidence of an association between hyperuricemia and the risk for gout. Increasing prevalence of gout and hyperuricemia has been reported in many countries. The prevalence of gout and hyperuricemia are constantly increasing in Korea with the patients at risk for developing a variety of comorbidities. Although there have been studies on the association between gout or serum uric acid level and several neurodegenerative diseases, cancer, and cardiovascular mortality, the causal relationship between gout and these comorbidities are still unclear. The associations of substantial economic burden with hyperuricemia, gout attack, and suboptimal treatment are well known. Gout is a disease that requires lifelong management including lifestyle modification. However, gout is poorly managed worldwide although effective urate-lowering drugs exist. In this review, we addressed epidemiological studies and treatment-related problems in the Korean population with gout or hyperuricemia to obtain the best clinical outcomes and reduce their medical burden.
3.Calcium Pyrophosphate Dihydrate (CPPD)Crystal Deposition Disease Mimicking Meningitis:A case Report and Review of the Literature.
Chan Hong JEON ; Won Hyeok CHOE ; Joong Kyong AHN ; Jay Hyun KOH ; Hoon Suk CHA ; Joong Mo AHN ; Eun Mi KOH
The Journal of the Korean Rheumatism Association 2001;8(2):134-139
Calcium pyrophosphate dihydrate (CPPD)crystal deposition disease is one of the most common causes of arthralgia in elderly.The acute form (pseudogout) may present as acute monoarticular or polyarticular arthritis.It is often accompanied by high fever and sometimes simulates acute infectious condition.The knee is the joint most frequently affected by pseudogout but other sites such as wrist,shoulder,ankle,elbow and hands may be affected.A few cases involving cervical and lumbar spine mistaken for CNS infection have also been described in foreign countries.We report here a case of CPPD crystal deposition disease mimicking meningitis.
Arthralgia
;
Calcium Pyrophosphate*
;
Calcium*
;
Chondrocalcinosis
;
Fever
;
Hand
;
Joints
;
Knee
;
Meningitis
;
Spine
4.Correlation of DEFA1 Gene Copy Number Variation with Intestinal Involvement in Behcet's Disease.
Joong Kyong AHN ; Hoon Suk CHA ; Jaejoon LEE ; Chan Hong JEON ; Eun Mi KOH
Journal of Korean Medical Science 2012;27(1):107-109
Copy number variation has been associated with various autoimmune diseases. We investigated the copy number (CN) of the DEFA1 gene encoding alpha-defensin-1 in samples from Korean individuals with Behcet's disease (BD) compared to healthy controls (HC). We recruited 55 BD patients and 35 HC. A duplex Taqman(R) real-time PCR assay was used to assess CN. Most samples (31.1%) had a CN of 5 with a mean CN of 5.4 +/- 0.2. There was no significant difference in the CN of the DEFA1 gene between BD patients and HC. A high DEFA1 gene CN was significantly associated with intestinal involvement in BD patients. Variable DEFA1 gene CNs were observed in both BD patients and HC and a high DEFA1 gene CN may be associated with susceptibility to intestinal involvement in BD.
Adult
;
Behcet Syndrome/*complications/*genetics
;
Female
;
Gene Dosage
;
Genetic Predisposition to Disease
;
Genotype
;
Humans
;
Intestinal Diseases/*etiology/*genetics
;
Male
;
Middle Aged
;
Real-Time Polymerase Chain Reaction
;
alpha-Defensins/*genetics
5.Extracellular High-Mobility Group Box 1 is Increased in Patients with Behcet's Disease with Intestinal Involvement.
Joong Kyong AHN ; Hoon Suk CHA ; Eun Kyung BAE ; Jaejoon LEE ; Eun Mi KOH
Journal of Korean Medical Science 2011;26(5):697-700
High-mobility group box 1 (HMGB1) protein has been demonstrated to play an important role in chronic inflammatory diseases including rheumatoid arthritis, and systemic lupus erythematosus. This study investigated the association between extracellular HMGB1 expression and disease activity, and clinical features of Behcet's disease (BD). Extracellular HMGB1 expression in the sera of 42 BD patients was measured and was compared to that of 22 age- and sex-matched healthy controls. HMGB1 expression was significantly increased in BD patients compared to healthy controls (78.70 +/- 20.22 vs 10.79 +/- 1.90 ng/mL, P = 0.002). In addition, HMGB1 expression was significantly elevated in BD patients with intestinal involvement compared to those without (179.61 +/- 67.95 vs 61.89 +/- 19.81 ng/mL, P = 0.04). No significant association was observed between HMGB1 concentration and other clinical manifestations, or disease activity. It is suggested that extracellular HMGB1 may play an important role in the pathogenesis of BD.
Adult
;
Aged
;
Behcet Syndrome/genetics/*metabolism/pathology
;
Extracellular Space/metabolism
;
Female
;
HMGB1 Protein/genetics/*metabolism
;
Humans
;
Inflammation
;
Intestinal Diseases/blood/genetics
;
Male
;
Middle Aged
;
Young Adult
6.A Case of Relapsing Polychondritis Presenting with Diffuse Tracheobronchial Involvement.
Kyung Mo YOO ; Jiwon HWANG ; Joong Kyong AHN
Journal of Rheumatic Diseases 2015;22(6):374-377
Relapsing polychondritis is a rare autoimmune disease involving the cartilaginous structures of the whole body. Its diagnosis can be difficult when the typical clinical features such as auricular chondritis are absent. Here, we report on a case of a 51-year-old female who presented with cough, dyspnea, and polyarthritis. Chest computed tomography showed the diffuse involvement of tracheobronchial cartilage. According to Damiani's criteria, she was diagnosed as relapsing polychondritis even though there was no unique involvement of auricular cartilage, and high dose steroid and immunosuppressive therapy were then started. This case indicated that patients who have tracheobronchial cartilage involvement without definite auricular chondritis should be considered for relapsing polychondritis as a differential diagnosis.
Arthritis
;
Autoimmune Diseases
;
Cartilage
;
Cough
;
Diagnosis
;
Diagnosis, Differential
;
Dyspnea
;
Ear Cartilage
;
Female
;
Humans
;
Middle Aged
;
Polychondritis, Relapsing*
;
Thorax
7.Rheumatoid Factor Positivity is Associated with Lower Bone Mass in Korean Male Health Examinees without Clinically Apparent Arthritis.
Jiwon HWANG ; Joong Kyong AHN ; Jaejoon LEE ; Eun Mi KOH ; Hoon Suk CHA
Journal of Rheumatic Diseases 2019;26(1):31-40
OBJECTIVE: This cross-sectional study aimed to investigate the association between rheumatoid factor (RF) positivity and bone mineral density (BMD) in male Korean subjects without any history of joint disease. METHODS: Of 84,344 males who had undergone a comprehensive health checkup program in 2012, 1,390 male health examinees were recruited, whose BMD and RF results were available. A RF titer ≥20 IU/mL was considered positive. BMD was measured at lumbar spine (L1~L4) or hip (femoral neck and total hip) by dual-energy X-ray absorptiometry. RESULTS: The association between RF positivity and BMD was assessed by multiple linear regression analysis. The mean age was 52.7±10.9 years (range 19~88 years), and RF was detected in 64 subjects (4.6%). Demographics and laboratory data were not different between RF-positive and -negative subjects except hepatitis B surface antigen (HBsAg), which was more frequently seen in RF-positive subjects (15.6% vs. 4.3%, p=0.001). RF-positive subjects had significantly lower BMD compared to RF-negative subjects in lumbar spine but not in total hip regardless of the existence of HBsAg (1.17±0.16 g/cm2 vs. 1.10±0.18 g/cm2, p=0.002 in total subjects; 1.17±0.16 g/cm2 vs. 1.10±0.18 g/cm2, p=0.004 in HBsAg-negative subjects). After adjusting for multiple confounders, RF positivity was negatively associated with lumbar spine BMD (B=−0.088 and standard error=0.035, p=0.011). CONCLUSION: Our results show that the presence of RF could have an unfavorable impact on bone density in apparently normal males. Additional studies to elucidate the osteoimmunological mechanism of rheumatoid factor are warranted.
Absorptiometry, Photon
;
Arthritis*
;
Bone Density
;
Cross-Sectional Studies
;
Demography
;
Hepatitis B Surface Antigens
;
Hip
;
Humans
;
Joint Diseases
;
Linear Models
;
Male*
;
Men's Health
;
Neck
;
Rheumatoid Factor*
;
Spine
8.Slug suppression induces apoptosis via Puma transactivation in rheumatoid arthritis fibroblast-like synoviocytes treated with hydrogen peroxide.
Hoon Suk CHA ; Eun Kyung BAE ; Joong Kyong AHN ; Jaejoon LEE ; Kwang Sung AHN ; Eun Mi KOH
Experimental & Molecular Medicine 2010;42(6):428-436
Inadequate apoptosis contributes to synovial hyperplasia in rheumatoid arthritis (RA). Recent study shows that low expression of Puma might be partially responsible for the decreased apoptosis of fibroblast-like synoviocytes (FLS). Slug, a highly conserved zinc finger transcriptional repressor, is known to antagonize apoptosis of hematopoietic progenitor cells by repressing Puma transactivation. In this study, we examined the expression and function of Slug in RA FLS. Slug mRNA expression was measured in the synovial tissue (ST) and FLS obtained from RA and osteoarthritis patients. Slug and Puma mRNA expression in FLS by apoptotic stimuli were measured by real-time PCR analysis. FLS were transfected with control siRNA or Slug siRNA. Apoptosis was quantified by trypan blue exclusion, DNA fragmentation and caspase-3 assay. RA ST expressed higher level of Slug mRNA compared with osteoarthritis ST. Slug was significantly induced by hydrogen peroxide (H2O2) but not by exogenous p53 in RA FLS. Puma induction by H2O2 stimulation was significantly higher in Slug siRNA-transfected FLS compared with control siRNA-transfected FLS. After H2O2 stimulation, viable cell number was significantly lower in Slug siRNA-transfected FLS compared with control siRNA-transfected FLS. Apoptosis enhancing effect of Slug siRNA was further confirmed by ELISA that detects cytoplasmic histone-associated DNA fragments and caspase-3 assay. These data demonstrate that Slug is overexpressed in RA ST and that suppression of Slug gene facilitates apoptosis of FLS by increasing Puma transactivation. Slug may therefore represent a potential therapeutic target in RA.
Apoptosis/*drug effects/genetics
;
Apoptosis Regulatory Proteins/*genetics/metabolism
;
Arthritis, Rheumatoid/genetics/metabolism/*pathology
;
Cells, Cultured
;
Drug Evaluation, Preclinical
;
Fibroblasts/drug effects/metabolism/pathology
;
Humans
;
Hydrogen Peroxide/*pharmacology
;
Proto-Oncogene Proteins/*genetics/metabolism
;
RNA, Small Interfering/*pharmacology
;
Synovial Membrane/cytology/drug effects/metabolism/*pathology
;
Transcription Factors/*antagonists & inhibitors/genetics
;
Transcriptional Activation/drug effects
;
Transfection
9.Predictive factors of radiographic progression in ankylosing spondylitis.
Hyungjin KIM ; Jaejoon LEE ; Joong Kyong AHN ; Jiwon HWANG ; Eun Jung PARK ; Hyemin JEONG ; Hoon Suk CHA ; Eun Mi KOH
The Korean Journal of Internal Medicine 2015;30(3):391-397
BACKGROUND/AIMS: The course of ankylosing spondylitis (AS) is rather variable, and the factors that predict radiographic progression remain largely obscure. In this study, we tried to determine the clinical factors and laboratory measures that are useful in predicting the radiographic progression of patients with AS. METHODS: In 64 consecutive patients with AS, we collected radiographic and laboratory data over 3 years. Radiographic data included images of the sacroiliac (SI) and hip joints and laboratory data included areas under the curve (AUC) of erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), alkaline phosphatase (ALP), and hemoglobin (Hb). We investigated associations among changes in radiographic scores, initial clinical manifestations and laboratory measurements. RESULTS: Changes in scores for the SI joint and lumbar spine did not correlate with AUC for ESR, CRP, or ALP. AUC for Hb did not significantly correlate with radiographic progression in any joint. Patients with hip arthritis at the initial visit showed significantly higher radiographic score changes after 3 years in the SI and hip joint compared to those without hip arthritis. Patients who had shoulder arthritis as the initial manifestation had significantly increased AUCs for ESR and CRP compared to those without shoulder arthritis. However, at 3 years, the change of the lumbar spine score was significantly higher in patients without shoulder arthritis. CONCLUSIONS: These results indicate that hip arthritis at presentation is a useful clinical marker for predicting the structural damage to the SI and hip joint, and suggest that initial shoulder arthritis correlates with slower radiographic progression of the lumbar spine.
Adolescent
;
Adult
;
Alkaline Phosphatase/blood
;
Biomarkers/blood
;
Blood Sedimentation
;
C-Reactive Protein/metabolism
;
Disease Progression
;
Female
;
Hemoglobins/metabolism
;
Hip Joint/*radiography
;
Humans
;
Male
;
Osteoarthritis, Hip/blood/*radiography
;
Predictive Value of Tests
;
Retrospective Studies
;
Risk Factors
;
Sacroiliac Joint/*radiography
;
Severity of Illness Index
;
Spondylitis, Ankylosing/blood/*radiography
;
Time Factors
;
Young Adult
10.The Prevalence of Gout among Hyperuricemic Population.
Eung Ho KIM ; Kyeongman JEON ; Keon Woo PARK ; Hyung Jin KIM ; Joong Kyong AHN ; Chan Hong JEON ; Hoon Suk CHA ; Eun Mi KOH
The Journal of the Korean Rheumatism Association 2004;11(1):7-13
OBJECTIVE: To investigate the prevalence of gout among hyperuricemic Korean people who visited Health Screening Center and to study related factors in the development of gout. METHODS: The medical records of 6,461 people who visited Health Screening Center from March to May in 2002 were reviewed. Five hundred twenty one out of 603 hyperuricemic individuals were interviewed by telephone. Gout was diagnosed according to the clinical criteria of Wallace. Basic demographic and lifestyle variables as well as biochemical data were collected. RESULTS: The prevalence of hyperuricemia was 14.3% in men and 2.2% in women. The prevalence of gout among hyperuricemic population was 16.6% for men and 6.7% for women. The mean age was higher in gout patients compared to the hyperuricemic people without gout, and serum uric acid and creatinine levels were increased in gout patients. The mean systolic blood pressure and the alcohol consumption amount were also increased in gout patients. In the multiple logistic regression analysis, statistically significant related factors for the development of gout among hyperuricemic population were age, uric acid level and alcohol consumption amount. CONCLUSION: The prevalence of gout among hyperuricemic Korean people who visited Health Screening Center was 16.6% for men and 6.7% for women. The possible related factors in the development of gout among hyperuricemic population were age, uric acid level and alcohol consumption amount.
Alcohol Drinking
;
Blood Pressure
;
Creatinine
;
Female
;
Gout*
;
Humans
;
Hyperuricemia
;
Life Style
;
Logistic Models
;
Male
;
Mass Screening
;
Medical Records
;
Prevalence*
;
Telephone
;
Uric Acid